News

July 31, 2019August 26, 2019

Team Will Use $10K Award to Bring Anti-lymphedema Bra to Market

News

A team of recent University of Iowa (UI) graduates who designed a bra to help breast cancer patients prevent a condition called lymphedema will use a $10,000 award to try ... Read more

July 29, 2019July 29, 2019

Anixa Partners with Cleveland Clinic to Take Breast Cancer Vaccine to Human Trials

News

Anixa Biosciences, a leading company developing anti-cancer immunotherapies, is partnering with the Cleveland Clinic to advance a vaccine against triple-negative breast cancer (TNBC) to testing in humans. “We are pleased ... Read more

July 26, 2019

FDA Approves Clinical Testing of Minerva’s CAR T-cell Therapy for Metastatic BC

News

Minerva Biotechnologies will soon start the first human trials testing its investigational therapy huMNC2-CAR44, a CAR T-cell immunotherapy intended for breast cancer that has spread to other parts of the ... Read more

July 24, 2019

Combining Breast, Lung Cancer Therapies Could Overcome Treatment Resistance

News

Combining Ibrance (palbociclib), a treatment for advanced breast cancer, with the lung cancer medicine crizotinib is more effective against human cancer cells in the laboratory than either drug alone, scientists have found. ... Read more

July 22, 2019

Antibody-Drug Conjugate Shows Efficacy in Heavily Treated Cancers

News

An investigational antibody-drug conjugate made of the HER2-targeting antibody trastuzumab (marketed as Herceptin and others) attached to a kind of chemotherapy compound has demonstrated notable efficacy in heavily treated patients ... Read more

July 19, 2019

Genomic Analysis Reveals Differences Between Cancer Cell Lines and Human Cancers

News

New research using “big data” helps highlight the differences between breast cancer cell lines and actual patient samples. This could allow researchers to choose models that more accurately reflect what ... Read more

July 17, 2019

Trilaciclib-Chemo Combo Extends Lives of Triple-negative Breast Cancer Patients, Preliminary Phase 2 Findings Show

News

Trilaciclib, a treatment that protects the bone marrow from the damaging effects of chemotherapy, significantly extends the lives of women with metastatic triple-negative breast cancer receiving a chemotherapy regimen of ... Read more

July 15, 2019July 15, 2019

$20M Gift to Dana-Farber Will Establish Fund for Metastatic Breast Cancer Research

News

The Dana-Farber Cancer Institute will get $20 million to create the Saverin Breast Cancer Research Fund aimed at extending the lives of metastatic breast cancer patients. The gift from the ... Read more

July 12, 2019July 12, 2019

Balixafortide-Halaven Combo Seen to Prolong Survival in Advanced Breast Cancer Patients in Phase 1 Trial

News

A combination of Polyphor‘s investigational therapy balixafortide (POL6326) and Eisai‘s Halaven (eribulin) may prolong the survival of women with HER2-negative metastatic breast cancer, a Phase 1 trial shows. The findings were ... Read more

July 10, 2019

Obesity Reprograms Immune Cells in Mammary Tissues to Promote Tumor Development, Study Says

News

Obesity in women with triple-negative breast cancer, the most aggressive kind of breast cancer, reprograms immune cells and creates a chronic inflammatory environment that promotes cancer progression and spread, a ... Read more